scholarly journals Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia cells

Oncotarget ◽  
2020 ◽  
Vol 11 (11) ◽  
pp. 943-955 ◽  
Author(s):  
Tomoya Aikawa ◽  
Noriko Togashi ◽  
Koichi Iwanaga ◽  
Hiroyuki Okada ◽  
Yumi Nishiya ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Leukemia Cells ◽  
Antileukemic Activity ◽  
Preclinical Models ◽  
Flt3 Inhibitor ◽  
Acute Myeloid Leukemia Cells ◽  
Acute Myeloid

Combined Antileukemic Activity of pIXY 321 and Ara-C against Human Acute Myeloid Leukemia Cells

1994 ◽  
Vol 15 (5-6) ◽  
pp. 445-451 ◽  
Author(s):  
Caroline Tang ◽  
Yue Huang ◽  
Vidya S. Ponnathpur ◽  
Swapan Ray ◽  
Mary Ella Mahoney ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Leukemia Cells ◽  
Antileukemic Activity ◽  
Human Acute Myeloid Leukemia ◽  
Acute Myeloid Leukemia Cells ◽  
Acute Myeloid

Effect of miR-128 in DNA Damage of HL-60 Acute Myeloid Leukemia Cells

2014 ◽  
Vol 15 (5) ◽  
pp. 492-502 ◽  
Author(s):  
Hugo Seca ◽  
Raquel Lima ◽  
Gabriela Almeida ◽  
Manuel Sobrinho-Simoes ◽  
Rui Bergantim ◽  
...  
Keyword(s):  
Dna Damage ◽  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Leukemia Cells ◽  
Acute Myeloid Leukemia Cells ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document